Express Scripts relaunches its Canada website
Express Scripts Canada said it has relaunched its website in order to account for the growing amount of mobile use in the country on Monday. Read More »
Express Scripts Canada said it has relaunched its website in order to account for the growing amount of mobile use in the country on Monday. Read More »
Progressive Care said on Monday that it has entered into a 340B contract with Empower "U," a nonprofit organization, through its subsidiary, Pharmco, LLC. 340B contracts let eligible organizations and their contracted pharmacies buy medications at a discounted rate. Read More »
While price increases across the health care industry are slowing, the costs of prescription drugs continues to skyrocket, according to Altarum Institute. Current figures, though, may show signs of moderation, an expert said. Read More »
The Asthma and Allergy Foundation of America (AAFA) released results on Friday from a survey that indicated people with colds, coughs or allergies prefer full access to medications containing pseudoephedrine (PSE). Read More »
Personalized medicine company Restore Health announced July 17 it will seek accreditation from health care accreditation organization URAC for its specialty pharmacy division. Read More »
Specialty infusion company Amerita was awarded specialty pharmacy accreditation July 17 from URAC, the independent and nonprofit leader in the accreditation of health and managed care organizations. Read More »
Epiduo Forte Gel, a new antibiotic-free treatment for acne from Galderma Laboratories, received approval from the U.S. Food and Drug Administration (FDA) on July 17. Read More »
Safe and Affordable Prescription Drugs Act of 2015 would amend the Federal Food, Drug, and Cosmetic Act Read More »
Pharmacy Technician Educators Council honors ASHP director of special publishing. Read More »
TeaserTheranos, Inc. and AmeriHealth Caritas announced July 15 a national strategic partnership to improve health outcomes by providing greater access to less invasive, more efficient diagnostic tests for Medicaid members. Read More »
Irving, California site will allow subsidiary, Mesa Pharmacy, to expand. Read More »
Mylan NV announced the launch of memantine hydrochloride tablets USP, 5 mg and 10 mg, the generic version of Forest's Namenda Tablets, in the United States on Tuesday. Mylan received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for memantine hydrochloride tablets, used for treating moderate to severe Alzheimer's-type dementia. Read More »
The Senior Care Pharmacy Coalition (CSPC) said Wednesday it commends California Gov. Jerry Brown for signing into law legislation that brings needed reforms to abusive Pharmacy Benefit Manager pricing and reimbursement practices. Ohio Gov.John Kasich signed a similar bill into law last week. Read More »
As the number of online pharmacies dispensing over the counter medicines increases, global players view India as a fertile ground for online pharmacies due to the availability of a diverse patient pool and presence of many Indian and multinational drug companies. Read More »
The National Community Pharmacists Association (NCPA) today announced that three teams of pharmacy students have been named finalists in the 2015 Good Neighbor Pharmacy NCPA Pruitt-Schutte Student Business Plan Competition. Read More »
BioPlus Specialty Pharmacy, a pioneer in innovative pharmaceutical care, on Tuesday announced the release of an updated version of the HCV Treatment Path app. Read More »
According to an ASHP survey, pharmacists in hospitals across the U.S. are performing more medication-related patient transition of care interventions, 24/7 medication order review and patient medication counseling. Read More »
Prime Aid Pharmacy was recently awarded both URAC Specialty Pharmacy and Mail Order Pharmacy accreditation. Read More »
Geneva Woods Pharmacy Inc. on Monday announced a big equity investment by Chugach Alaska Corporation and other Alaska-based investors, who together have acquired a minority interest in the company. Read More »
Gilead Sciences, Inc. said it submitted a new drug application to the U.S. Food and Drug Administration (FDA) on July 1 for an investigational, once-a-day single-tablet regimen for the treatment of HIV-1 infection in patients ages 12 and older. Read More »